Aspire BioPharma, Inc. Defensive Interval Ratio

Latest as of March 2025: 2 days

Aspire BioPharma, Inc. defensive interval ratio. Aspire BioPharma, Inc. (ASBP) has a Defensive Interval Ratio of 2 days as of March 2025. Defensive assets of $36.50K (cash $-, short-term investments $-, receivables $36.50K) cover 2 days of daily cash needs of $24.30K/day. See Aspire BioPharma, Inc. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

2 days
Days of operational coverage

Defensive Assets

$36.50K
Cash + ST Investments + Receivables

Daily Cash Need

$24.30K
Current Liabilities ÷ 365

Current Liabilities

$8.87 Million
USD

Defensive Interval Ratio of Aspire BioPharma, Inc. (2024–2024)

Defensive interval ratio of Aspire BioPharma, Inc. from 2024 to 2024. This chart shows how Aspire BioPharma, Inc.'s Defensive Interval Ratio has evolved across 1 annual periods from 2024 to 2024. As of March 2025, the ratio stands at 2 days, meaning defensive assets of $36.50K can fund 2 days of operations without new revenue. Read Aspire BioPharma, Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.

Aspire BioPharma, Inc. Defensive Interval Ratio by Year (2024–2024)

Aspire BioPharma, Inc. defensive interval ratio by year from 2024 to 2024. The table below presents the year-by-year Defensive Interval Ratio for Aspire BioPharma, Inc. from 2024 to 2024, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see ASBP current and non-current assets.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 8 days $36.50K $4.62K/day $- $- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)